Medical Genomics

Integration of comprehensive multi-omic data to improve patient outcomes

Dr Nic Waddell

Senior Group Leader

Research Focus

The Medical Genomics Team analyses next generation sequence data to address clinical challenges in a variety of diseases. The approaches we take include:

  • Characterising cancer genomes with short and long read sequencing to diagnosis the genetic cause of disease;
  • Machine learning (ML) to predict patient outcomes and identify novel biomarkers;
  • Computational immunogenomics to identify genomic and transcriptomic features associated with prognosis and treatment;
  • Bioinformatic approaches to understand tumour heterogeneity and the tumour micro-environment;
  • Identification of mutational processes that underlie tumour development.

Ultimately, we aim to take steps towards ‘personalised medicine’ to enable the diagnosis, management and treatment of patients.

Gallery

Research Projects

Current Research Projects

Cancer Genomics

Integrated multi-omic analysis for machine learning to predict patient outcomes

Cancer Immunotherapy


Research Team

Miranda Vidgen

Bonnie Wong

Georgina Hollway

Venkateswar Addala


Funding

  • National Health and Medical Research Council (NHMRC)
  • Cancer Council Queensland
  • Cancer Australia
  • Ian Potter Foundation
  • QIMR Berghofer

Publications

Addala V et al. Computational immunogenomic approaches to predict response to cancer immunotherapies. Nature Reviews Clinical Oncology. 2023 doi: 10.1038/s41571-023-00830-6. PMID: 37907723

Tran K et al. Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures. Nature Communications. 2023 14(1):5758. doi: 10.1038/s41467-023-41385-5. PMID: 37717006

Naeini MN et al. Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. Nature Communications. 2023 14(1):3155. doi: 10.1038/s41467-023-38891-x. PMID: 37258531

Read more

Further Information



External Collaborations
  • Andrew Barbour, Princess Alexandra Hospital and Frazer Institute, University of Queensland
  • David Fielding, RBWH
  • Peter Simpson, UQCCR, University of Queensland
  • Sunil Lakhani and Amy McCart Reed, UQCCR, The University of Queensland
  • Bruce Robinson, Jenette Creaney and Alec Redwood, NCARD and University of Western Australia
  • Lata Vadlamudi, RBWH and UQCCR, University of Queensland
  • James Wilmot, Melanoma Institute Australia
  • Professor Kiarash Khosrotehrani, Frazer Institute, University of Queensland
  • Aldo Scarpa, University of Verona
  • Australian Genomics
  • Pam Pollock, Queensland University of Technology
  • Sean Grimmond, VCCC, University of Melbourne
  • genomiQa Pty Ltd